⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KYTX News
Kyverna Therapeutics, Inc. Common Stock
Kyverna Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Kyverna Therapeutics, Inc. - KYTX
businesswire.com
KYTX
Kyverna Therapeutics Announces Publication of Registrational Miv-cel Data in Patients with Stiff Person Syndrome in JAMA Neurology
globenewswire.com
KYTX
Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference
globenewswire.com
KYTX
Kyverna Therapeutics Highlights Promising Updated Clinical Data with Miv-cel in Progressive Multiple Sclerosis at MS Toronto 2026
globenewswire.com
KYTX
Did Kyverna Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
KYTX
Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
globenewswire.com
KYTX
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
globenewswire.com
KYTX
Form 8-K
sec.gov
KYTX
Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
globenewswire.com
KYTX
Kyverna Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
KYTX